Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Wolf-Hirschhorn syndrome candidate 1-like 1 pseudogene (ENSG00000255174) is a human genomic sequence classified as a pseudogene, related in sequence to the WHSC1L1 gene. Pseudogenes are DNA sequences resembling known genes but are generally non-functional due to mutations that prevent their transcription or translation into biologically active proteins[5][8]. There is no evidence that this pseudogene encodes a protein or acts as a functional molecular target. Its functional relatives — such as WHSC1 (NSD2) and WHSC1L1 (NSD3) — play roles in gene regulation (histone methylation), cancer, and development, but the pseudogene does not participate in these processes[1][7]. No drugs directly target pseudogenes, nor do they serve as recognized biomarkers or therapeutic targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Wolf-Hirschhorn syndrome candidate 1-like 1 pseudogene.